Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics Revenue

In the year 2023, Aquestive Therapeutics had annual revenue of $50.58M with 6.09% growth. Revenue in the quarter ending December 31, 2023 was $13.21M with 23.63% year-over-year growth.

• Revenue (ttm): $50.58M
• Revenue Growth: +6.09%
• P/S Ratio: 6.26
• Revenue / Employee: $374,689
• Employees: 135
• Market Cap: 316.69M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	50.58M	2.90M	6.09%
Dec 31, 2022	47.68M	-3.15M	-6.20%
Dec 31, 2021	50.83M	4.98M	10.87%
Dec 31, 2020	45.85M	-6.76M	-12.85%
Dec 31, 2019	52.61M	-14.82M	-21.98%
Dec 31, 2018	67.43M	512.00K	0.77%
Dec 31, 2017	66.92M	15.13M	29.22%
Dec 31, 2016	51.79M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.